|
|
Zyprexa Class Action Lawsuits Information
Zyprexa was FDA approved for the short-term treatment of
acute manic episodes in bipolar disorder. The world’s best selling schizophrenia
drug, Zyprexa sales account for 40% of Eli Lilly’s $11.08 billion in sales.
There have been many questions regarding the popular drug Zyprexa and its
safety. Linked to 288 reported Zyprexa diabetes cases, including 23 deaths, the
Zyprexa concerns were so great that Japan and the European Union required that
diabetes warnings be included on Zyprexa labeling.
The Public Citizen consumer group thinks the FDA has not adequately warned
physicians and Zyprexa patients of the Zyprexa risks. Hyperglycemia, diabetes,
and ketoacidosis have been reported amongst Zyprexa patients. Ketoacidosis,
associated to Zyprexa adverse effects reports end up fatal in about 50% of the
cases. The last time the Zyprexa labeling was updated in the U.S. the FDA only
made a quick reference to the risk of Zyprexa diabetes and hyperglycemia in the
middle of the adverse reactions section of Zyprexa labeling.
Zyprexa Side Effects
Zyprexa side effects have included serious events, including
hyperglycemia, diabetes, and ketoacidosis. The potentially fatal Zyprexa side
effects have resulted in Zyprexa lawsuits. So alarming, the Zyprexa side effects
caused the Japanese and British authorities to issue emergency safety
information in April 2002. In the U.S., however, consumer group Public Citizen,
does not think the FDA has done enough to warn physicians or patients of the
risks of Zyprexa side effects, disguising warnings in wordy drug labeling.
The FDA has identified there have been 384 reports of diabetes Zyprexa side
effects. Most of the diabetes Zyprexa side effects were suffered within six
months of beginning the schizophrenia treatment. The Public Citizen has
recommended Zyprexa patients follow the Zyprexa side effects advice in the
absence of FDA issued recommendations.
More Zyprexa Information
Information on Zyprexa has continued to indicate there are
potentially fatal effects. The risks of suffering side effects information on
Zyprexa is not reaching physicians and patients according to Public Citizen
consumer group, a possible reason why Zyprexa has continued to be the world’s
best selling schizophrenia drug. According to the FDA’s information on Zyprexa,
there have been 384 Zyprexa diabetes reports made. Due to vast underreporting
thought to exist, the actual number of adverse events suffered cannot be
accurately portrayed in the FDA information on Zyprexa.
So successful so far, Zyprexa manufacturer Eli Lilly has been seeking FDA
approval on an injectable form of Zyprexa, however the FDA found information on
the Zyprexa indicating there were manufacturing quality assurance flaws. More
and more Zyprexa lawsuits are being filed representing patients that suffered
serious adverse effects because they did not receive warning information on
Zyprexa that it could occur.
Initially viewed as wonder drugs, information on Zyprexa may not have been fully
known when first entering the market and now Zyprexa is being prescribed for
indications beyond schizophrenia.
For more free legal information on known dangerous drugs and Class Action Lawsuits, please use the
links below:
|